Tomás G. Lyons
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- PARP inhibition in cancer therapy
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
Papers in
- Oncology 13
- Cancer Treatment and Pharmacology 4
- HER2/EGFR in Cancer Research 4
- PARP inhibition in cancer therapy 4
- Cancer Immunotherapy and Biomarkers 3
- Cancer-related Molecular Pathways 2
-
- Advanced Breast Cancer Therapies 7
- Co-authors
- Geoffrey Y. Ku (2 shared papers)Tiffany A. Traina (5 shared papers)Mark E. Robson (1 shared paper)Catherine M. Kelly (3 shared papers)Grainne M. O’Kane (2 shared papers)Derek G. Power (1 shared paper)Eoin C. Kavanagh (1 shared paper)David Fitzpatrick (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Breast Cancer Research and Treatment (2 papers)European Journal of Cancer (2 papers)Expert Opinion on Drug Safety (1 paper)Journal of the National Comprehensive Cancer Network (1 paper)
- Partner nations
- United StatesIreland
In The Last Decade
Tomás G. Lyons
18 papers receiving 447 citations
Peers
Comparison fields: 5 of 62
- Oncology 181
- Cancer Research 73
- Molecular Biology 192
- Pulmonary and Respiratory Medicine 78
- Immunology 49
Countries citing papers authored by Tomás G. Lyons
This map shows the geographic impact of Tomás G. Lyons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomás G. Lyons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomás G. Lyons more than expected).
Fields of papers citing papers by Tomás G. Lyons
This network shows the impact of papers produced by Tomás G. Lyons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomás G. Lyons. The network helps show where Tomás G. Lyons may publish in the future.
Co-authors
The 25 scholars most cited alongside Tomás G. Lyons, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 247 | |
| 2 | 2020 | 32 | |
| 3 | 2017 | 30 | |
| 4 | 2014 | 27 | |
| 5 | 2016 | 22 | |
| 6 | 2019 | 18 | |
| 7 | 2017 | 17 | |
| 8 | 2018 | 17 | |
| 9 | 2014 | 11 | |
| 10 | 2018 | 10 | |
| 11 | 2017 | 5 | |
| 12 | Vismodegib in the treatment of advanced BCC. | 2014 | 4 |
| 13 | 2020 | 2 | |
| 14 | 2015 | 2 | |
| 15 | 2011 | 2 | |
| 16 | 2018 | 2 | |
| 17 | 2013 | 1 | |
| 18 | 2017 | 1 |
About Tomás G. Lyons
Tomás G. Lyons is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Genetics and Cardiology and Cardiovascular Medicine, having authored 18 papers that have together received 450 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (7 papers), Cancer Treatment and Pharmacology (4 papers), HER2/EGFR in Cancer Research (4 papers), PARP inhibition in cancer therapy (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), BRCA gene mutations in cancer (2 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Oncology (181 citations), Cancer Research (73 citations), Molecular Biology (192 citations), Pulmonary and Respiratory Medicine (78 citations) and Immunology (49 citations). Tomás G. Lyons has collaborated with scholars based in United States and Ireland. Frequent co-authors include Geoffrey Y. Ku, Tiffany A. Traina, Mark E. Robson, Catherine M. Kelly, Grainne M. O’Kane, Derek G. Power, Eoin C. Kavanagh, David Fitzpatrick, Cynthia Heffron and Sandra Murphy. Their work appears in journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment, European Journal of Cancer, Expert Opinion on Drug Safety and Journal of the National Comprehensive Cancer Network.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.